Abstract:Background: Picroside I, a hepatoprotectant, can reduce liver injury in humans and animals. However, its anti-fibrosis effect remains unclear. This study aims to explore the mechanism of the hepatoprotective effect of picroside I on hepatic fibrosis. Methods: Male mice (12 per group) were randomly divided into six groups: control group; model group, given thioacetamide (TAA); positive group, given TAA + S-(5′-adenosyl)-L-methionine (10 mg·kg−1); low-dose group, given TAA + picroside I (25 mg·kg−1); middle-dose group, given TAA + picroside I (50 mg·kg−1); and high-dose group, given TAA + picroside I (75 mg·kg−1). Serum biochemical indicators were detected, and histological evaluation was performed. Metabolomics and proteomic analyses were conducted using liquid-chromatography coupled with tandem mass spectrometry.Findings: Picroside I can decrease the serum alanine transaminase, aspartate transaminase, collagen type IV, N-terminal peptide of type III procollagen, laminin, and hyaluronic acid levels and reduce the fibrosis area in a dose-dependent manner. In addition, picroside I altered the metabolomic profiling in hepatic fibrosis mice, including 10 urine metabolites, 16 serum metabolites, and 8 liver metabolites. Twenty-five differentially expressed proteins were reversed in the picroside I high-dose-treated group compared with the model group. Interpretation: Our results reveal whether and how picroside I protects against TAA-induced liver fibrosis in mice. Funding: National Natural Science Foundation of China, Program of Shanghai Academic/Technology Research Leader, S&T Major Special Projects, Xinglin Talent Program of Shanghai University of Traditional Chinese Medicine.Funding Statement: This work was financially supported by National Natural Science Foundation of China (project No. 81503223), the Program of Shanghai Academic/Technology Research Leader (18XD1403700; 17XD1403500), National Science and Technology (S&T) Major Special Projects (2017ZX09309006), and Xinglin Talent Program of Shanghai University of Traditional Chinese Medicine (SHUTCM2017).Declaration of Interests: The authors declare no conflicts of interest.Ethics Approval Statement: The animal experiments were approved by the Institutional Animal Care and Use Committee of Shanghai University of Traditional Chinese Medicine.

Abscisic Acid Ameliorates Oxidative Stress, Inflammation, and Apoptosis in Thioacetamide-Induced Hepatic Fibrosis by Regulating the NF-кB Signaling Pathway in Mice.

TAK-242 Ameliorates Hepatic Fibrosis by Regulating the Liver-Gut Axis

Albiflorin ameliorates thioacetamide-induced hepatic fibrosis: The involvement of NURR1-mediated inflammatory signaling cascades in hepatic stellate cells activation

Tao-Hong-Si-Wu-Tang improves thioacetamide-induced liver fibrosis by reversing ACSL4-mediated lipid accumulation and promoting mitophagy

Allyl Isothiocyanate Ameliorates Lipid Accumulation and Inflammation in Nonalcoholic Fatty Liver Disease Via the Sirt1/AMPK and NF-κB Signaling Pathways.

Simultaneous Modulation of NLRP3 Inflammasome and Nrf2/ARE Pathway Rescues Thioacetamide-Induced Hepatic Damage in Mice: Role of Oxidative Stress and Inflammation

Dihydromyricetin Reverses Thioacetamide-Induced Liver Fibrosis Through Inhibiting NF-κB-Mediated Inflammation and TGF-β1-Regulated of PI3K/Akt Signaling Pathway

Abscisic acid for acute respiratory distress syndrome therapy by suppressing alveolar macrophage pyroptosis via upregulating acyloxyacyl hydrolase expression

α-Bisabolol and royal jelly differentially mitigate thioacetamide-induced hepatic fibrosis in rats associated with the inhibition of TGF-β1/FAK/α-SMA signaling

α-Lipoic acid modulates liver fibrosis: A cross talk between TGF-β1, autophagy, and apoptosis

Association of resveratrol with the suppression of TNF-α/NF-kB/iNOS/HIF-1α axis-mediated fibrosis and systemic hypertension in thioacetamide-induced liver injury

Abscisic acid inhibited reactive oxygen species‐mediated endoplasmic reticulum stress by regulating the PPAR‐γ signaling pathway in ARDS mice

[Alcohol extract of root and root bark of Toddalia asiatica alleviates CIA in rats through anti-inflammatory and proapoptotic effects]

Suppression of iNOS/HIF-1α/MMP-9/α-SMA/collagen Axis of Fibrosis and Systemic Hypertension in Thioacetamide-induced Liver Injury by Resveratrol

Ameliorative effect of grape seed proanthocyanidin extract on thioacetamide-induced mouse hepatic fibrosis.

Combination of pomegranate extract and curcumin ameliorates thioacetamide-induced liver fibrosis in rats: impact on TGF-β/Smad3 and NF-κB signaling pathways

Lead-induced liver fibrosis and inflammation in mice by the AMPK/MAPKs/NF-κB and STAT3/TGF-β1/Smad2/3 pathways: the role of Isochlorogenic acid a

Thymoquinone protects thioacetamide‐induced chronic liver injury by inhibiting TGF‐β1/Smad3 axis in rats

Lactoferrin as a therapeutic agent for attenuating hepatic stellate cell activation in thioacetamide-induced liver fibrosis

Hepatoprotective Effect of Picroside I on Thioacetamide-Induced Hepatic Fibrosis Determined by Metabolomic and Proteomic Analyses